Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Nanomedicine Market, by Region, 2018-2027 (USD Billion)
1.2.2. Nanomedicine Market, by Modality, 2018-2027 (USD Billion)
1.2.3. Nanomedicine Market, by Application, 2018-2027 (USD Billion)
1.2.4. Nanomedicine Market, by Indication, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Nanomedicine Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Nanomedicine Market Dynamics
3.1. Nanomedicine Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Nanomedicine Market Industry Analysis
4.1. Porters 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porters 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Nanomedicine Market, by Modality
5.1. Market Snapshot
5.2. Global Nanomedicine Market by Modality, Performance - Potential Analysis
5.3. Global Nanomedicine Market Estimates & Forecasts by Modality 2017-2027 (USD Billion)
5.4. Nanomedicine Market, Sub Segment Analysis
5.4.1. Diagnostics
5.4.2. Treatments
Chapter 6. Global Nanomedicine Market, by Application
6.1. Market Snapshot
6.2. Global Nanomedicine Market by Application, Performance - Potential Analysis
6.3. Global Nanomedicine Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
6.4. Nanomedicine Market, Sub Segment Analysis
6.4.1. Drug Delivery
6.4.2. Vaccines
6.4.3. Diagnostic Imaging
6.4.4. Regenerative Medicine
6.4.5. Implants
6.4.6. Others
Chapter 7. Global Nanomedicine Market, by Indication
7.1. Market Snapshot
7.2. Global Nanomedicine Market by Indication - Potential Analysis
7.3. Global Nanomedicine Market Estimates & Forecasts by Indication 2017-2027 (USD Billion)
7.4. Nanomedicine Market, Sub Segment Analysis
7.4.1. Oncological Diseases
7.4.2. Infectious Diseases
7.4.3. Cardiovascular Diseases
7.4.4. Orthopedic Disorders
7.4.5. Neurological Diseases
7.4.6. Others
Chapter 8. Global Nanomedicine Market, Regional Analysis
8.1. Nanomedicine Market, Regional Market Snapshot
8.2. North America Nanomedicine Market
8.2.1. U.S. Nanomedicine Market
8.2.1.1. Modality breakdown estimates & forecasts, 2017-2027
8.2.1.2. Application breakdown estimates & forecasts, 2017-2027
8.2.1.3. Indication breakdown estimates & forecasts, 2017-2027
8.2.2. Canada Nanomedicine Market
8.3. Europe Nanomedicine Market Snapshot
8.3.1. U.K. Nanomedicine Market
8.3.2. Germany Nanomedicine Market
8.3.3. France Nanomedicine Market
8.3.4. Spain Nanomedicine Market
8.3.5. Italy Nanomedicine Market
8.3.6. Rest of Europe Nanomedicine Market
8.4. Asia-Pacific Nanomedicine Market Snapshot
8.4.1. China Nanomedicine Market
8.4.2. India Nanomedicine Market
8.4.3. Japan Nanomedicine Market
8.4.4. Australia Nanomedicine Market
8.4.5. South Korea Nanomedicine Market
8.4.6. Rest of Asia Pacific Nanomedicine Market
8.5. Latin America Nanomedicine Market Snapshot
8.5.1. Brazil Nanomedicine Market
8.5.2. Mexico Nanomedicine Market
8.6. Rest of The World Nanomedicine Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Abbott Laboratories
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. CombiMatrix Corp.
9.2.3. General Electric
9.2.4. Johnson & Johnson
9.2.5. Mallinckrodt Pharmaceuticals
9.2.6. Merck & Co., Inc.
9.2.7. Luminex Corporation
9.2.8. Pfizer Inc.
9.2.9. Leadiant Biosciences, Inc.
9.2.10. Teva Pharmaceutical Industries Ltd.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption